Comparison of the Effect of Amiodaron and Propafenone on Cardioversion of Paroxysmal Auricular Fibrillation
- VernacularTitle:静脉注射胺碘酮与心律平转复阵发心房颤动的疗效比较
- Author:
Zong-jun LI
;
Zhi WANG
- Publication Type:Journal Article
- Keywords:
auricular fibrillation, amiodaron, propafenone, cardioversion
- From:
Chinese Journal of Rehabilitation Theory and Practice
2006;12(7):608-609
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo compare the effect of amiodaron and propafenone on the cardioversion of paroxysmal auricular fibrillation (PAF). Methods58 PAF (≤48 h) cases were radomly divide into two groups: 30 cases who accepted amiodaron 150 mg intravenous injection, and 0.6～1.0 mg/min intravenous drip afterwards in amiodaron group, other 28 cases who accepted propafenone 1.4～2.0 mg/kg vein injection, and 0.28 mg/min intravenous drip afterwards in propafenone group.If propafenone was not effective, the cases in propafenone group were given amidoaron. ResultsThe successful reversion rate was 86.7% (26/30) in amidoaron group while 57.1% (16/28) in propafenone group(P<0.05). The mean time of recovering was (101±95) min (6～508 min) in amidoaron group, while (172±148) min (11～608 min) in propafenone group(P<0.05). ConclusionIt is more rapid and effective of amidoaron on the cardioversion of paroxysmal auricular fibrillation than propafenone is.
